1 suspended. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Suspended 1 |
| Phase 2 | 1 | Suspended 1 |
Follow MetaPhore Pharmaceuticals: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of M40403 for the Prevention of Dose Limiting Toxicities of High Dose IL-2 M40403 - IL-2 Induced Hypotension | Phase 1 / Phase 2 | Suspended | MetaPhore Pharmaceuticals | 48 | 2001-12-01 | 2005-06-24 |
Carcinoma, Renal Cell (1) · Hypotension (1) · Melanoma (1)
United States (1)